Waking up to sleeping sickness

Pepin, 2001, The epidemiology and control of human African trypanosomiasis, Adv. Parasitol., 49, 71, 10.1016/S0065-308X(01)49038-5 Smith, 1998, Human African trypanosomiasis: an emerging public health crisis, Br. Med. Bull., 54, 341, 10.1093/oxfordjournals.bmb.a011692 Dumas, 1999, Clinical aspects of human African trypanosomiasis, 215 Pepin, 1989, Trial of prednisolone for prevention of melarsoprol-induced encephalopathy in gambiense sleeping sickness, Lancet, 1, 1246, 10.1016/S0140-6736(89)92340-4 Burri, 2000, Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial, Lancet, 355, 1419, 10.1016/S0140-6736(00)02141-3 Matovu, 2001, Drug resistance in Trypanosoma brucei spp., the causative agents of sleeping sickness in man and nagana in cattle, Microbes Infect., 3, 763, 10.1016/S1286-4579(01)01432-0 Keiser, 2001, New drugs for the treatment of human African trypanosomiasis: research and development, Trends Parasitol., 17, 42, 10.1016/S1471-4922(00)01829-8 Rogers, 2002, A response to the aim of eradicating tsetse from Africa, Trends Parasitol., 18, 534, 10.1016/S1471-4922(02)02422-4 Sones, 2002, Tsetse control: the next 100 years, Trends Parasitol., 18, 523, 10.1016/S1471-4922(02)02419-4 Stanghellini, 2001, The situation of sleeping sickness in Angola: a calamity, Trop. Med. Int. Health, 6, 330, 10.1046/j.1365-3156.2001.00724.x Legros, 2002, Treatment of human African trypanosomiasis – present situation and needs for research and development, Lancet Infect. Dis., 2, 437, 10.1016/S1473-3099(02)00321-3